Alwin Willcure Pharmaceuticals Private Limited, a active private limited company, was established on 11 March 2019 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230DL2019PTC347077. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Ravi Lalwani (Director), Surjeet Kumar (Director). It holds ₹1.13 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.N. 85 First Floor, Right Portion Bharat Nagar Village, New Delhi, Delhi, 110044.
U24230DL2019PTC347077
347077
11 March 2019
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Alwin Willcure Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Lalwani | Director | 11 Mar 2019 | Current |
| Surjeet Kumar | Director | 11 Mar 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alwin Willcure Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.63% increase. The company also saw a substantial improvement in profitability, with a 26.19% increase in profit. The company's net worth Soared by an impressive increase of 141.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Alwin Willcure Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹11,280,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jun 2024 | Others | ₹1.28 M | Open |
| 29 May 2024 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Alwin Willcure Pharmaceuticals has a workforce of 3 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alwin Willcure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alwin Willcure Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Alwin Willcure Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge with Others amounted to Rs. 1.28 M with Charge ID 100933242 was registered on 03 Jun 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 10.00 M with Charge ID 100948661 was registered on 29 May 2024. was recorded as a recent event.
Progress on Alwin Willcure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Ravi Lalwani was appointed as a Director was appointed as a Director on 11 Mar 2019 & has been associated with this company since 6 years 8 months . was completed.
Progress on Surjeet Kumar was appointed as a Director was appointed as a Director on 11 Mar 2019 & has been associated with this company since 6 years 8 months . was documented.
The CIN of Alwin Willcure Pharmaceuticals Private Limited is U24230DL2019PTC347077.
Alwin Willcure Pharmaceuticals Private Limited is headquartered at H.N. 85 First Floor, Right Portion Bharat Nagar Village, New Delhi, Delhi, 110044.
Alwin Willcure Pharmaceuticals Private Limited was incorporated on 11 March 2019.
The current directors of Alwin Willcure Pharmaceuticals Private Limited are
The primary industry of Alwin Willcure Pharmaceuticals Private Limited is Trade.
Alwin Willcure Pharmaceuticals Private Limited is unlisted.
The authorized capital of Alwin Willcure Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Alwin Willcure Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX